Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated Individuals - Concepedia

Concepedia

Publication | Open Access

Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated Individuals

DOI Full Paper Access

33

Citations

14

References

2023

Year

Sarah E. Smith-Jeffcoat, Jessica E Biddle, H. Keipp Talbot, Kerry Grace Morrissey, Melissa S. Stockwell, Yvonne Maldonado, Huong Q. McLean, Katherine Ellingson, Natalie M. Bowman, Edwin J. Asturias,

Clinical Infectious Diseases

Abstract

Individuals who completed N/R treatment experienced fewer symptoms and lower VL but rebound occured more often compared with untreated individuals. Providers should prescribe N/R, when indicated, and communicate rebound risk to patients.

References

	Year	Citations

Page 1